Back
HFA Premium Access

Clinical experience with novel K+ binders: what are the opportunities and challenges?

logo

Session: The hyperkalaemia challenge in heart failure: what is the role of novel agents?
Topic: Treatment
Speaker: Professor C. Linde (Stockholm, SE) Professor A. Stewart Coats (Sydney, AU) Professor M. Volterrani (Rome, IT)
Sponsored by AstraZeneca
Event: Heart Failure 2019

Congress Presentation

Add to my library

Like

About the speakers

Professor Cecilia Marianne Linde

Karolinska Institute, Stockholm (Sweden)
72 presentations
10 followers

Professor Andrew Stewart Coats

Heart Research Institute, Sydney (Australia)
113 presentations
23 followers

Professor Maurizio Volterrani

IRCCS San Raffaele, Rome (Italy)
20 presentations
8 followers

4 more presentations in this session

Chair's introduction - The hyperkalaemia challenge in heart failure: what is the role of novel agents?

Speaker: Professor A. Stewart Coats (Sydney, AU)

Access
Like
Thumbnail

What is the clinical impact of hyperkalaemia?

Speaker: Professor C. Linde (Stockholm, SE)

Access
Like
Thumbnail

Hyperkalaemia: a barrier to optimal management of patients with heart failure?

Speaker: Professor A. Stewart Coats (Sydney, AU)

Access
Like
Thumbnail

Solving the K+ challenge in heart failure: are novel K+ binders the answer?

Speaker: Professor M. Volterrani (Rome, IT)

Access
Like
Thumbnail

Access the full session

The hyperkalaemia challenge in heart failure: what is the role of novel agents?

Speakers: Professor C. Linde, Professor A. Stewart Coats, Professor M. Volterrani, Professor A. Stewart Coats, Professor C. Linde...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources